Precision Medicine – What Does it Mean for Drug Development and Disease Prevention?
Jeffry Cheah Distinguished Speaker Series : Precision Medicine – What Does it Mean for Drug Development and Disease Prevention?
by Professor John Todd
Jeffrey Cheah Fellow in Medicine, Brasenose College, Oxford;
Professor of Precision Medicine, University of Oxford;
Director, Wellcome Centre for Human Genetics;
Director, JDRF/Wellcome Diabetes and Inflammation Laboratory
Date : 1 December 2022 (Thursday)
Time : 4:30PM - 6PM (Malaysia Time)
Venue : JC2, Level 1, Sunway University
Recent advances in biotechnology coupled with a rapidly increasing understanding of the fundamental genetic causes of disease are not only identifying those at risk of disease but also revealing new drug targets.
Going forward, we are entering an era of next generation medicine in which therapeutics and healthcare will be targeted at the specific causes of disease increasing drug safety and efficacy.
In this lecture, Professor John Todd will discuss what precision medicine means for drug development and disease prevention.